LexaGene Holdings Inc. LXXGF
Trading inactive
LXXGF
LexaGene Holdings Inc. ATBPF
Antibe Therapeutics Inc. VRCDF
Verici Dx plc TMDIF
Titan Medical Inc. CNPOF
RIV Capital Inc. HOPHF
Hemogenyx Pharmaceuticals Plc EIGRQ
Eiger BioPharmaceuticals, Inc. LVCLY
Living Cell Technologies Limited RXMD
Progressive Care, Inc. MGCLF
MGC Pharmaceuticals Limited
LexaGene Holdings Inc. ATBPF
Antibe Therapeutics Inc. VRCDF
Verici Dx plc TMDIF
Titan Medical Inc. CNPOF
RIV Capital Inc. HOPHF
Hemogenyx Pharmaceuticals Plc EIGRQ
Eiger BioPharmaceuticals, Inc. LVCLY
Living Cell Technologies Limited RXMD
Progressive Care, Inc. MGCLF
MGC Pharmaceuticals Limited
Performance
| Periode | LXXGF | ATBPF | VRCDF | TMDIF | CNPOF | HOPHF | EIGRQ | LVCLY | RXMD | MGCLF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -16.91 % | -0.19 % | -74.67 % | -9.92 % | -21.57 % | 87.90 % | 255.65 % | -31.45 % | 19.89 % | -24.86 % |
| YTD | -31.11 % | -0.19 % | -74.67 % | -44.76 % | 0.00 % | 87.90 % | 20.57 % | -38.80 % | -36.83 % | -18.06 % |
| 1Y | -53.68 % | -0.19 % | -74.67 % | -52.47 % | -8.83 % | 87.90 % | 3.79 % | -54.33 % | -46.65 % | -94.75 % |
| 3Y | -78.44 % | -59.34 % | -96.00 % | -96.83 % | -92.86 % | -58.69 % | -95.68 % | -69.40 % | 5 310.26 % | -99.32 % |
| 5Y | -91.24 % | -95.55 % | -97.08 % | -93.83 % | -92.66 % | 1 692.31 % | -97.33 % | -69.82 % | 5 452.63 % | -99.28 % |
| 10Y | -79.85 % | -83.79 % | -97.08 % | -99.93 % | -98.85 % | 1 692.31 % | -99.81 % | -93.05 % | 3 416.67 % | -99.33 % |
| Depuis le début | -79.85 % | -95.48 % | -97.08 % | -93.01 % | -98.85 % | 1 692.31 % | -99.77 % | -96.81 % | 4 120.00 % | -99.33 % |